Cover Image

Prescription drug therapies : reducing costs and improving outcomes /

The report describes Agency for Healthcare Research and Quality (AHRQ) funded research that helps to answer questions about prescription medicine. AHRQ research has identified conditions for which drug therapy is not necessary. It has discovered low-cost drug therapies that provide patients with the...

Full description

Bibliographic Details
Main Author:	Kass-Bartelmes, Barbara L.
Corporate Author:	United States. Agency for Healthcare Research and Quality
Other Authors:	Bosco, Lynn
Format:	Government Document eBook
Language:	English
Published:	Rockville, Md. : Agency for Healthcare Research and Quality, [2002]
Series:	Research in action (United States. Agency for Healthcare Research and Quality) ; issue #8. AHRQ publication ; no. 02-0045.
Subjects:	Prescription pricing > United States > Costs. Chemotherapy > Economic aspects > United States. Drug Prescriptions > economics > United States. Drug Therapy > economics > United States. Drug Therapy > methods > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS91729

Similar Items

Prescription drugs : expanding access to federal prices could cause other price changes : report to congressional requesters /
Published: (2000)

Guide to prescription drug costs /
Published: (1980)

Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018.
Published: (2020)

The $800 million pill : the truth behind the cost of new drugs /
by: Goozner, Merrill, 1950-
Published: (2004)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

The cost of prescription drugs : an examination of the National Academies of Sciences, Engineering, and Medicine report "Making Medicines Affordable: A National Imperative" : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session on examining the cost of prescription drugs, focusing on an examination of the National Academies of Sciences, Engineering, and Medicine report "Making Medicines Affordable: A National Imperative", December 12, 2017.
Published: (2022)

Sales, promotion, and product differentiation in two prescription drug markets /
by: Bond, Ronald S., et al.

Prescription drug costs : a bitter pill to swallow : joint hearing before the Subcommittee on Housing and Consumer Interests and the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, September 28, 1992, Logansport, IN.
Published: (1993)

Prescription drugs : prices available through discount cards and from other sources.
by: Dummit, Laura A.
Published: (2001)

Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1990)

Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1889.
Published: (1990)

Reasonable Rx : solving the drug price crisis /
by: Finkelstein, Stan N.
Published: (2008)

The new handbook of prescription drugs: official names, prices, and sources for patient and doctor.
by: Burack, Richard
Published: (1970)

Prescription drugs : is there a cure for the costs? : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, January 16, 1992, Vancouver, WA.
Published: (1993)

Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001.
Published: (2002)

The demand for prescription drugs as a function of cost-sharing /
by: Leibowitz, Arleen A.
Published: (1985)

Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2009)

Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2009)

Prescriptive authority for psychologists : a history and guide /
Published: (2003)

Potential effects of a ban on direct-to-consumer advertising of new prescription drugs.
by: Campbell, Sheila (Sheila Marie)
Published: (2011)

Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /
by: Jaggar, Sarah F.
Published: (1996)

Frequently asked questions about prescription drug pricing and policy /
by: Kirchhoff, Suzanne M., et al.
Published: (2018)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

Sudden price spikes in decades-old prescription drugs : inside the monopoly business model : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, March 17, 2016.
Published: (2022)

The effect of cost-sharing on the utilization of prescription drugs for chronically ill patients /
by: Solomon, Matthew D.
Published: (2005)

Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers [as printed] : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, September 5, 2001.
Published: (2003)

The complex web of prescription drug prices : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC.
Published: (2022)

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

The right price : a value-based prescription for drug costs /
by: Neumann, Peter J., 1961-, et al.
Published: (2021)

Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N.
Published: (2006)

Prescription drug advertising to consumers : staff report /
Published: (1984)

The role of pharmacy benefit managers in prescription drug markets : report prepared by the House Committee on Oversight and Accountability staff.
Published: (2024)

Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)

Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)

South Florida's access to affordable prescription drugs : costs and benefits of alternative solutions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, March 10, 2003.
Published: (2003)

South Florida's access to affordable prescription drugs : costs and benefits of alternative solutions : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, March 10, 2003.
Published: (2003)

The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018.
Published: (2020)

Saunders equine formulary /
by: Knottenbelt, Derek C.
Published: (2006)

Medicaid outpatient prescription drugs : second quarter 2008 federal upper limits for reimbursement compared with average retail pharmacy acquisition costs : [letter to Charles E. Grassley, Ranking Member, Committee on Finance, United States Senate /
by: Dicken, John E.
Published: (2009)